EC: 2.1.1.6
catechol O-methyltransferase (S-adenosyl-L-methionine:catechol O-methyltransferase)
Pathways
| pathway id | name |
|---|---|
| BioCyc:META_PWY6666-2 | dopamine degradation |
| BioCyc:META_PWY-6342 | noradrenaline and adrenaline degradation |
| BioCyc:META_PWY-6334 | L-dopa degradation |
| BioCyc:MOUSE_PWY6666-2 | dopamine degradation |
| BioCyc:HUMAN_PWY6666-2 | dopamine degradation |
| BioCyc:HUMAN_PWY-6334 | L-dopa degradation |
| BioCyc:HUMAN_PWY-6342 | noradrenaline and adrenaline degradation |
| Reactome:R-HSA-9679506 | SARS-CoV Infections |
| Reactome:R-HSA-9679191 | Potential therapeutics for SARS |
| Reactome:R-HSA-9824446 | Viral Infection Pathways |
| Reactome:R-BTA-1430728 | Metabolism |
| Reactome:R-BTA-379397 | Enzymatic degradation of dopamine by COMT |
| Reactome:R-DRE-112315 | Transmission across Chemical Synapses |
| Reactome:R-DRE-112311 | Neurotransmitter clearance |
| Reactome:R-HSA-211859 | Biological oxidations |
| Reactome:R-HSA-156581 | Methylation |
| Reactome:R-HSA-112315 | Transmission across Chemical Synapses |
| Reactome:R-HSA-112311 | Neurotransmitter clearance |
| Reactome:R-HSA-1643685 | Disease |
| Reactome:R-MMU-1430728 | Metabolism |
| Reactome:R-MMU-211859 | Biological oxidations |
| Reactome:R-MMU-156581 | Methylation |
| Reactome:R-MMU-379398 | Enzymatic degradation of Dopamine by monoamine oxidase |
| Reactome:R-RNO-112316 | Neuronal System |
| Reactome:R-RNO-379401 | Clearance of dopamine |
| Reactome:R-BTA-211859 | Biological oxidations |
| Reactome:R-BTA-156581 | Methylation |
| Reactome:R-BTA-112316 | Neuronal System |
| Reactome:R-BTA-379401 | Clearance of dopamine |
| Reactome:R-DRE-379398 | Enzymatic degradation of Dopamine by monoamine oxidase |
| Reactome:R-HSA-156580 | Phase II - Conjugation of compounds |
| Reactome:R-HSA-379398 | Enzymatic degradation of Dopamine by monoamine oxidase |
| Reactome:R-MMU-156580 | Phase II - Conjugation of compounds |
| Reactome:R-MMU-379397 | Enzymatic degradation of dopamine by COMT |
| Reactome:R-RNO-211859 | Biological oxidations |
| Reactome:R-RNO-156581 | Methylation |
| Reactome:R-RNO-112315 | Transmission across Chemical Synapses |
| Reactome:R-RNO-112311 | Neurotransmitter clearance |
| Reactome:R-BTA-379398 | Enzymatic degradation of Dopamine by monoamine oxidase |
| Reactome:R-DRE-112316 | Neuronal System |
| Reactome:R-DRE-379401 | Clearance of dopamine |
| Reactome:R-DRE-1430728 | Metabolism |
| Reactome:R-DRE-156580 | Phase II - Conjugation of compounds |
| Reactome:R-HSA-112316 | Neuronal System |
| Reactome:R-HSA-379401 | Clearance of dopamine |
| Reactome:R-MMU-112315 | Transmission across Chemical Synapses |
| Reactome:R-MMU-112311 | Neurotransmitter clearance |
| Reactome:R-RNO-1430728 | Metabolism |
| Reactome:R-RNO-379397 | Enzymatic degradation of dopamine by COMT |
| Reactome:R-BTA-156580 | Phase II - Conjugation of compounds |
| Reactome:R-BTA-112315 | Transmission across Chemical Synapses |
| Reactome:R-BTA-112311 | Neurotransmitter clearance |
| Reactome:R-DRE-379397 | Enzymatic degradation of dopamine by COMT |
| Reactome:R-DRE-211859 | Biological oxidations |
| Reactome:R-DRE-156581 | Methylation |
| Reactome:R-HSA-1430728 | Metabolism |
| Reactome:R-HSA-379397 | Enzymatic degradation of dopamine by COMT |
| Reactome:R-HSA-5663205 | Infectious disease |
| Reactome:R-MMU-112316 | Neuronal System |
| Reactome:R-MMU-379401 | Clearance of dopamine |
| Reactome:R-RNO-156580 | Phase II - Conjugation of compounds |
| Reactome:R-RNO-379398 | Enzymatic degradation of Dopamine by monoamine oxidase |
| WikiPathways:WP4220 | Neurotransmitter disorders |
| WikiPathways:WP4156 | Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine |
| PathBank:SMP0120674 | Alkaptonuria |
| PathBank:SMP0120782 | Dopamine beta-Hydroxylase Deficiency |
| PathBank:SMP0000190 | Hawkinsinuria |
| PathBank:SMP0000327 | Phenytoin (Antiarrhythmic) Action Pathway |
| PathBank:SMP0120729 | Tyrosinemia Type I |
| PathBank:SMP0120817 | Monoamine Oxidase-A Deficiency (MAO-A) |
| PathBank:SMP0120491 | Hawkinsinuria |
| PathBank:SMP0000169 | Alkaptonuria |
| PathBank:SMP0000429 | Disulfiram Action Pathway |
| PathBank:SMP0087365 | Estrone Metabolism |
| PathBank:SMP0063684 | Tyrosine Metabolism |
| PathBank:SMP0120453 | Alkaptonuria |
| PathBank:SMP0120509 | Tyrosinemia Type I |
| PathBank:SMP0120598 | Monoamine Oxidase-A Deficiency (MAO-A) |
| PathBank:SMP0000218 | Tyrosinemia Type I |
| PathBank:SMP0000533 | Monoamine Oxidase-A Deficiency (MAO-A) |
| PathBank:SMP0087272 | Estrone Metabolism |
| PathBank:SMP0087328 | Tyrosine Metabolism |
| PathBank:SMP0120711 | Hawkinsinuria |
| PathBank:SMP0120779 | Tyrosinemia, Transient, of the Newborn |
| PathBank:SMP0030880 | Estrone Metabolism |
| PathBank:SMP0120559 | Tyrosinemia, Transient, of the Newborn |
| PathBank:SMP0120563 | Dopamine beta-Hydroxylase Deficiency |
| PathBank:SMP0000006 | Tyrosine Metabolism |
| PathBank:SMP0000494 | Tyrosinemia, Transient, of the Newborn |
| PathBank:SMP0000498 | Dopamine beta-Hydroxylase Deficiency |
| PathBank:SMP0087235 | Tyrosine Metabolism |
| PathBank:SMP0063696 | Estrone Metabolism |